These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14653030)

  • 1. Angiogenesis--a new goal in peripheral artery occlusive disease therapy.
    Mäkinen K
    Acta Chir Belg; 2003 Oct; 103(5):470-4. PubMed ID: 14653030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
    Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
    J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization].
    Kalka C; Asahara T; Krone W; Isner JM
    Herz; 2000 Sep; 25(6):611-22. PubMed ID: 11076319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic neoangiogenesis of peripheral arteries].
    Engelmann MG; Nikol S
    Herz; 2000 Sep; 25(6):600-10. PubMed ID: 11076318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic.
    Rissanen TT; Vajanto I; Ylä-Herttuala S
    Eur J Clin Invest; 2001 Aug; 31(8):651-66. PubMed ID: 11473566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic angiogenesis for ischemic diseases].
    Aoki M; Morishita R
    Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers.
    Altavilla D; Bitto A; Polito F; Marini H; Minutoli L; Di Stefano V; Irrera N; Cattarini G; Squadrito F
    Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):313-21. PubMed ID: 19860658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases.
    Aoki M; Morishita R; Taniyama Y; Kaneda Y; Ogihara T
    J Atheroscler Thromb; 2000; 7(2):71-6. PubMed ID: 11426585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds.
    Nikol S; Pelisek J; Engelmann MG; Shimizu M; Fuchs A; Golda A; Armeanu S; Mekkaoui C; Rolland PH
    J Endovasc Ther; 2002 Dec; 9(6):842-54. PubMed ID: 12546587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic growth factors in the treatment of peripheral arterial disease.
    Mikroulis D; Papanas N; Maltezos E; Bougioukas G
    Curr Vasc Pharmacol; 2007 Jul; 5(3):195-209. PubMed ID: 17627563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs.
    Nikol S; Engelmann MG; Pelisek J; Fuchs A; Golda A; Shimizu M; Mekkaoui C; Rolland PH
    Acta Physiol Scand; 2002 Oct; 176(2):151-9. PubMed ID: 12354175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriogenesis: lessons learned from clinical trials.
    Baklanov D; Simons M
    Endothelium; 2003; 10(4-5):217-23. PubMed ID: 14660081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis-a novel therapeutic approach for ischemic heart disease.
    Nessa A; Latif SA; Siddiqui NI; Hussain MA; Bhuiyan MR; Hossain MA; Akther A; Rahman M
    Mymensingh Med J; 2009 Jul; 18(2):264-72. PubMed ID: 19623159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and angiogenesis.
    Hoeben A; Landuyt B; Highley MS; Wildiers H; Van Oosterom AT; De Bruijn EA
    Pharmacol Rev; 2004 Dec; 56(4):549-80. PubMed ID: 15602010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological revascularisation in coronary and peripheral vascular disease.
    Tarzami ST; Singh JP
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1319-26. PubMed ID: 15461560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
    Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M
    Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease.
    Bitto A; Polito F; Altavilla D; Minutoli L; Migliorato A; Squadrito F
    J Vasc Surg; 2008 Nov; 48(5):1292-300. PubMed ID: 18971038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.